Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI

• Published in: Ophthalmology and therapy Vol. 13; no. 6; pp. 1669 - 1682
• Main Authors: Pato-Cour, Esperanza, Borrego-Sanz, Lara, Domínguez-Álvaro, Marta, Sánchez-Alonso, Fernando, Rodríguez-González, Fayna, Tejera-Santana, Marta, Esteban-Ortega, Mar, García-Lozano, Isabel, Martínez-Costa, Lucia, González-Ocampo, Samuel, Sainz-de-la-Maza, Maite, Moll-Udina, Aina, Plaza, Zulema, Fonollosa, Alejandro, Artaraz, Joseba, Díaz-Valle, Teresa, Gurrea-Almela, Maria, Díaz-Valle, David, Méndez-Fernández, Rosalía
• Format: Journal Article
• Language: English
• Published: Cheshire Springer Healthcare 01.06.2024; Adis, Springer Healthcare
• Subjects: Composite index; Internal Medicine; Interobserver reliability; Medicine; Medicine & Public Health; Ophthalmology; Original Research; Sensitivity to change; UVEDAI; Uveitis; UVEDAI; Sensitivity to change; Interobserver reliability; Uveitis; Composite index
• ISSN: 2193-8245; 2193-6528
• DOI: 10.1007/s40123-024-00943-w

Introduction This was a multicenter, prospective, longitudinal, observational study involving eight Spanish tertiary hospitals to determine the interobserver reliability of an uveitis disease activity index, (UVEDAI) and assess its sensitivity to change in patients with receiving pharmacologic treatment. Methods Patients aged ≥ 18 years diagnosed with active noninfectious uveitis were included. A complete baseline assessment was performed by two ophthalmologists who determined ocular inflammatory activity using the UVEDAI index independently of each other. The principal ophthalmologist made a new visit at 4 weeks to determine the change in inflammatory activity. The interobserver reliability analysis was performed by calculating the intraclass correlation coefficient (ICC), with the values of the variables and the UVEDAI obtained by both ophthalmologists in the more active eye at the baseline visit. Sensitivity to change in the UVEDAI index was assessed at 4 weeks from the start of pharmacologic treatment by determining the clinically relevant change, defined as a change in UVEDAI of ≥ 0.8 points over baseline. The mean change between both measures was compared using the repeated-measures t -test. Results A total of 111 patients were included. In the interobserver reliability analysis, the ICC for the UVEDAI value was 0.9, and, when compared with the mean UVEDAI values obtained by the ophthalmologists, no statistically significant differences were found ( p value > 0.05). As for the sensitivity to change in UVEDAI, statistically significant differences ( p value = 0.00) were found for the mean values of the index compared with baseline. In all cases, the index value decreased by > 1 point at the 4-week visit. Conclusions The interobserver reliability of the UVEDAI was high in the total sample. Furthermore, the index was sensitive in determining the change in inflammatory activity after treatment. We believe that UVEDAI is a disease activity index that enables objective comparison of results in clinical practice and trials.